Location History:
- Tokyo, JP (1995 - 2013)
- Chuo-ku, JP (2009 - 2015)
Company Filing History:
Years Active: 1995-2015
Title: Keisuke Matsuura: Innovator in Pharmaceutical Compounds
Introduction
Keisuke Matsuura is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address renal diseases and related conditions. With a total of 5 patents to his name, Matsuura's work is recognized for its potential impact on medical treatments.
Latest Patents
One of Matsuura's latest patents is for a guanidinobenzoic acid compound. This compound is designed to serve as an agent for preventing and/or treating renal diseases. The invention arose from extensive studies on compounds with trypsin inhibitory action. The guanidinobenzoic acid compound has been found to effectively substitute low-protein diet therapy and can also aid in preventing and treating trypsin-related diseases such as pancreatitis and gastroesophageal reflux disease.
Another significant patent is for an amide compound, which serves as an active ingredient in pharmaceutical compositions aimed at treating chronic renal failure and diabetic nephropathy. This compound exhibits EP4 receptor antagonistic activity, confirming its potential as a treatment for various EP4-related diseases.
Career Highlights
Matsuura has worked with prominent companies in the pharmaceutical industry, including Astellas Pharma GmbH and Olympus Optical Company, Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Throughout his career, Matsuura has collaborated with notable colleagues such as Ryushi Seo and Eisuke Nozawa. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Keisuke Matsuura's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments for renal diseases. His patents reflect a deep understanding of complex biochemical interactions and a dedication to advancing healthcare solutions.